Fundz

Leyden Labs Raises $200M In 2021 For A New Approach To Combat Viruses

PRIVATEJan 25, 2022

Amount Raised

$200 Million

Round Type

Funding Round

LeidenBiotechnologyScience And Engineeringresearch

Description

Leyden Laboratories B.V., (the "Company" or "Leyden Labs") today announced closing a $140M Series B financing, bringing its total capital raised to approximately $200M in 2021. Series A investors Casdin Capital and GV (formerly Google Ventures) led the round that included incoming investors SoftBank Vision Fund 2, Invus, and Bluebird Ventures, and existing Series A investors F-Prime Capital and Byers Capital/Brook Byers. This international syndicate will support Leyden Labs’ mission to free people from the burden of respiratory viruses. The Board will expand to include Eli Casdin of Casdin Capital as a new member

Quick answer

Leyden Labs raised $200 Million in a Funding Round round, dated January 25, 2022. Leyden Labs is based in Leiden, South Holland, Netherlands.

How much did Leyden Labs raise?
Leyden Labs raised $200 Million in a Funding Round round on January 25, 2022.
What does Leyden Labs do?
Leyden Labs aims to help people live their lives to the fullest.
Where is Leyden Labs based and how big is it?
Leyden Labs is based in Leiden, South Holland, Netherlands. Fundz records about 66 employees.
Who are the decision-makers at Leyden Labs?
Fundz holds 2 contacts at Leyden Labs, including the Director Regulatory Affairs. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and research around the same time

Companies in the same sectors as Leyden Labs that raised within 45 days of this round, from Fundz verified event records.

  • Dewpoint Therapeutics raised $150M on February 4, 2022.
  • Dewpoint Therapeutics raised $150M (Series C) on February 3, 2022.
  • Scenic Biotech raised $31M (Funding Round) on March 10, 2022.
  • Genomenon, Inc. raised $20M on March 10, 2022.
  • Scenic Biotech raised an undisclosed amount (Series A) on March 10, 2022.
  • Psilera raised an undisclosed amount (Funding Round) on March 8, 2022.

Who to call at Leyden Labs, and when

A new round usually means Leyden Labs is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Leyden Labs raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Leyden Labs, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Leyden Labs. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Leyden Labs

Location

Emmy Noetherweg

Leiden, South Holland, Netherlands

About

Leyden Labs aims to help people live their lives to the fullest. Our platform targets commonalities of viral families to protect humanity from known and future viruses. Our portfolio of accessible intranasal product candidates may provide people with the freedom to immediately protect themselves from and prevent the spread of many variants of respiratory viruses, including ones in the influenza and coronavirus families. The Leyden Labs’ energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Leyden Labs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsJoana M., Director Regulatory Affairs hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Leyden Labs's next move

See what Strategic adds

Leyden Labs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.